| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3641MU2013IN2013MU03641A (en) | 2013-11-20 | 2014-11-19 | |
| PCT/IN2014/000724WO2015092810A2 (en) | 2013-11-20 | 2014-11-19 | Amorphous form of idelalisib |
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3641MU2013IN2013MU03641A (en) | 2013-11-20 | 2014-11-19 |
| Publication Number | Publication Date |
|---|---|
| IN2013MU03641Atrue IN2013MU03641A (en) | 2015-07-31 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3641MU2013IN2013MU03641A (en) | 2013-11-20 | 2014-11-19 |
| Country | Link |
|---|---|
| IN (1) | IN2013MU03641A (en) |
| WO (1) | WO2015092810A2 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016097314A1 (en)* | 2014-12-19 | 2016-06-23 | Sandoz Ag | Amorphous and crystalline forms of idelalisib and process for forming the same |
| WO2016147206A1 (en) | 2015-03-13 | 2016-09-22 | Mylan Laboratories Limited | Process for the preparation of amorphous idelalisib and its premix |
| WO2016157136A1 (en) | 2015-04-02 | 2016-10-06 | Mylan Laboratories Ltd | Crystalline forms of idelalisib |
| CN108033961A (en) | 2015-04-15 | 2018-05-15 | 上海方楠生物科技有限公司 | A kind of amorphous article of Ai Delibu and preparation method thereof |
| WO2017137097A1 (en)* | 2016-02-12 | 2017-08-17 | Synthon B.V. | Pharmaceutical composition comprising idelalisib in amorphous form |
| WO2017175184A1 (en)* | 2016-04-07 | 2017-10-12 | Laurus Labs Limited | Process for preparation of amorphous form of idelalisib |
| EP3272348A1 (en) | 2016-07-21 | 2018-01-24 | LEK Pharmaceuticals d.d. | Pharmaceutical composition comprising idelalisib |
| WO2019178596A1 (en) | 2018-03-16 | 2019-09-19 | Johnson Matthey Public Limited Company | Pyridine or n,n-dimethyl acetamide solvated solid state forms of solvated idelalisib, their use and preparation |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT1761540T (en)* | 2004-05-13 | 2017-02-27 | Icos Corporation | Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
| ES2848273T3 (en)* | 2012-03-05 | 2021-08-06 | Gilead Calistoga Llc | Polymorphic forms of (S) -2- (1- (9H-purin-6-ylamino) propyl) -5-fluoro-3-phenylquinazoline-4 (3H) -one |
| Publication number | Publication date |
|---|---|
| WO2015092810A3 (en) | 2015-08-13 |
| WO2015092810A2 (en) | 2015-06-25 |
| Publication | Publication Date | Title |
|---|---|---|
| PH12015501710A1 (en) | Combination formulation of two antiviral compounds | |
| MX2020005181A (en) | Aminopyridine derivatives as tam family kinase inhibitors. | |
| MX2021011906A (en) | Delayed release compositions of linaclotide. | |
| IN2015DN00127A (en) | ||
| AU2015287674B2 (en) | Topical antiviral compositions and methods of using the same | |
| MX2020001756A (en) | Benzoquinolone inhibitors of vmat2. | |
| IN2013MU03641A (en) | ||
| IN2013MU00646A (en) | ||
| MX345926B (en) | Novel compositions, preparation thereof and use thereof for production of cast polyamides. | |
| PH12016501686A1 (en) | Pharmaceutical compositions of sitagliptin | |
| IN2013MU00848A (en) | ||
| MY180844A (en) | Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions | |
| IL243435B (en) | High potery pancreatin pharmaceutical compositions | |
| IN2013MU03918A (en) | ||
| SG10201900598TA (en) | Factor viii formulation | |
| PL2968478T3 (en) | Compositions and methods for the treatment of carboxyhemoglobinemia | |
| IN2014CH00840A (en) | ||
| MX2015016603A (en) | Corticosteroid compositions. | |
| IN2013MU01113A (en) | ||
| EP3063152A4 (en) | Convenient preparation of n-substituted morphinan-6-ols from morphinan-6-ones | |
| NZ721832A (en) | Solid forms of tenofovir | |
| EP3016981A4 (en) | Compositions and methods for treatment of stroke | |
| IN2013MU03768A (en) | ||
| IN2013MU03317A (en) | ||
| IN2013MU02528A (en) |